Glycine receptor subunit beta (GLRB)

Glycine receptor subunit beta is a structural and functional component of the pentameric glycine receptor, a ligand-gated chloride channel chiefly expressed in the central nervous system, including the spinal cord, brainstem, and retina[1][2][3][4][5][7][9]. It does not bind glycine directly but is crucial for receptor assembly, proper synaptic localization, and stabilization by interacting with the scaffolding protein gephyrin[5][7]. The predominant functional glycine receptor in adults is the heteromeric assembly (typically 4 alpha:1 beta subunit stoichiometry), where the beta subunit enables synaptic clustering and modulates channel properties[2][3][7]. This receptor is essential for **fast inhibitory neurotransmission**, playing major roles in motor control, pain processing, and other CNS functions[3][5][7]. Mutations in the beta subunit cause hereditary startle disease (hyperekplexia) and are associated with chronic pain, epilepsy, and other neurological disorders[1][7]. Pharmacologically, it is targeted by classic convulsant poisons like strychnine (antagonist) and subject to various experimental modulators, though it is not a frequent direct target of marketed drugs[7][8][9].

Other names

Glycine receptor β subunitGLRBspa (in mouse studies)GlyR β subunit

Blockade of glycine binding (e.g., strychnine blocks the receptor leading to convulsions) - Inhibition of chloride ion influx (e.g., picrotoxin noncompetitively inhibits the receptor) - Positive allosteric modulation (e.g., ivermectin enhances Cl⁻ influx) - Modulation of synaptic clustering and stabilization (via protein-protein interaction with gephyrin)